Context In 2010, California experienced its largest pertussis epidemic in more than 60 years;
a substantial burden of disease was noted in the 7-to 10-year-old age group despite high …

Background. We conducted a 5-year follow-up study on the persistence of pertussis-specific
antibody and cell-mediated immunity after booster immunization of adolescents aged 11–13 …

Introduction To reduce the pertussis disease burden, nowadays several countries
recommend acellular pertussis (aP) booster vaccinations for adults. We aimed to evaluate …

OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …

Importance The United States has experienced a nationwide resurgence of pertussis since
the mid-1970s, despite high estimated vaccine coverage. Short-lived immunity induced by …

Availability of combined tetanus-diphtheria-acellular pertussis (Tdap) vaccines for adults
offers a new pertussis prevention strategy for the US. Successful uptake of Tdap vaccine will …

Background This study assessed the safety and immunogenicity of a new booster vaccine
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …

Three hundred and nineteen adolescents aged 10–12 years who had been previously
vaccinated with five doses of acellular pertussis-containing vaccines received single doses …

Importance There is accumulating literature on waning acellular pertussis vaccine–induced
immunity, confirming the results of studies assessing the duration of protection of pertussis …

Tetanus, diphtheria, and acellular pertussis vaccine (Tdap) is recommended for all adults in
Canada but uptake is low. This study measured the knowledge, attitudes, beliefs, and …